Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 47 Records) |
Query Trace: Hypertension and CYP2C9[original query] |
---|
Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study. Frontiers in pharmacology 2017 8 347. Claudio-Campos Karla, Labastida Aurora, Ramos Alga, Gaedigk Andrea, Renta-Torres Jessicca, Padilla Dariana, Rivera-Miranda Giselle, Scott Stuart A, Ruaño Gualberto, Cadilla Carmen L, Duconge-Soler Jor |
The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population. Clinical and experimental hypertension (New York, N.Y. : 1993) 2017 May 1-6. Polonikov Alexey, Bykanova Marina, Ponomarenko Irina, Sirotina Svetlana, Bocharova Anna, Vagaytseva Kseniya, Stepanov Vadim, Churnosov Mikhail, Bushueva Olga, Solodilova Maria, Shvetsov Yaroslav, Ivanov Vladim |
Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2017 Apr . Park Yun Kyung, Lee Mi Ji, Kim Jae Ha, Lee Jin Soo, Park Rae Woong, Kim Gyeong-Moon, Chung Chin-Sang, Lee Kwang Ho, Kim June Soo, Lee Soo-Youn, Bang Oh You |
Relationship between clopidogrel-related polymorphisms and variable platelet reactivity at 1 year: A cohort study from Han Chinese. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 2016 21 111. Wang Xiaodong, Lai Yan, Luo Yu, Zhang Xumin, Zhou Hua, Ye Zi, Tang Jiani, Liu Xue |
Interaction among CYP2C8, GPIIIa and P2Y12 variants increase susceptibility to ischemic stroke in Chinese population. Oncotarget 2017 Sep 8 (41): 70811-70820. Yi Xingyang, Lin Jing, Wang Yanfen, Zhou Ju, Zhou Qia |
Eicosanoids via CYP450 and cardiovascular disease: Hints from genetic and nutrition studies. Prostaglandins & other lipid mediators 2018 10 139 41-47. Fava Cristiano, Bonafini Sa |
Pharmacogenetics of Vascular Risk Factors in Alzheimer's Disease. Journal of personalized medicine 2018 Jan 8 (1): . Cacabelos Ramón, Meyyazhagan Arun, Carril Juan C, Cacabelos Pablo, Teijido Ósc |
Impact of genetic and clinical factors on warfarin therapy in patients early after heart valve replacement surgery. European journal of clinical pharmacology 2019 8 75 (12): 1685-1693. Li Boxia, Liu Ruisheng, Wang Chengqi, Ren Changan, Zhang Shiming, Zhang Fan, Zhang Jianping, Liu Shidong, Wei Yuhui, Liu Wenjing, Song Bing, Wu Xin |
The effect of genetic and nongenetic factors on warfarin dose variability in Qatari population. The pharmacogenomics journal 2019 Oct . Bader Loulia, Mahfouz Ahmad, Kasem Mohammed, Mohammed Shaban, Alsaadi Sumayya, Abdelsamad Osama, Elenani Rasha, Soaly Ezeldin, Elzouki Abdelnasser, Rizk Nasser, Khalifa Sherief, Shahin Mohamed H, Cavallari Larisa H, Mraiche Fatima, Elewa Haz |
[Association between cytochrome p4502c9 polymorphisms and losartan dosing in hypertensive patients]. Revista medica de Chile 2020 3 147 (12): 1527-1534. Pedreros-Rosales Cristian, Jalil Milad Roberto, Lagos Lucero Marcela, Solari Gajardo Sand |
The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia. Journal of clinical laboratory analysis 2021 Sep e23949. Wu Liting, Fan Yingchao, Wang Yuan, Li Zhumeng, Mao Delong, Zhuang Wenfa |
Rare variants discovery by extensive whole-genome sequencing of the Han Chinese population in Taiwan: Applications to cardiovascular medicine.
Journal of advanced research 2021 5 30 147-158. Juang Jyh-Ming Jimmy, Lu Tzu-Pin, Su Ming-Wei, Lin Chien-Wei, Yang Jenn-Hwai, Chu Hou-Wei, Chen Chien-Hsiun, Hsiao Yi-Wen, Lee Chien-Yueh, Chiang Li-Mei, Yu Qi-You, Hsiao Chuhsing Kate, Chen Ching-Yu Julius, Wu Pei-Ei, Pai Chien-Hua, Chuang Eric Y, Shen Chen-Ya |
A pilot study of oral treprostinil pharmacogenomics and treatment persistence in patients with pulmonary arterial hypertension. Therapeutic advances in respiratory disease 2021 4 15 17534666211013688. Coons James C, Crisamore Karryn, Adams Solomon, Modany Ashley, Simon Marc A, Zhao Wenchen, Shaik Imam H, Venkataramanan Raman, Empey Philip |
Distributive characteristics of the CYP2C9 and AGTR1 genetic polymorphisms in Han Chinese hypertensive patients: a retrospective study. BMC cardiovascular disorders 2021 Feb 21 (1): 73. Chen Keping, Xiao Peng, Li Guochun, Wang Chunling, Yang Chuank |
Association of Cytochrome P450 2C9*3 and Angiotensin II Receptor 1 (1166A>C) Gene Polymorphisms With the Antihypertensive Effect of Irbesartan. American journal of hypertension 2021 02 34 (1): 121. Dong Hui, Wang Feng-Zhen, Shi Kun, Zhang Xue-Shan, Lv Dong-M |
Physiologically based pharmacokinetic modeling of candesartan related to CYP2C9 genetic polymorphism in adult and pediatric patients. Archives of pharmacal research 2021 Nov . Jung Eui Hyun, Cho Chang-Keun, Kang Pureum, Park Hye-Jung, Lee Yun Jeong, Bae Jung-Woo, Choi Chang-Ik, Jang Choon-Gon, Lee Seok-Yo |
Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study. European journal of clinical pharmacology 2021 Oct . Mer?ep Iveta, Radman Ivana, Trkulja Vladimir, Božina Tamara, Šimi?evi? Livija, Budimir Ema, Ganoci Lana, Božina Na |
Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer. Frontiers in pharmacology 2022 13 918219. Tan Tingfei, Han Gongwei, Cheng Ziwei, Jiang Jiemei, Zhang Li, Xia Zitong, Wang Xinmeng, Xia Qu |
Association of AGTR1 A1166C and CYP2C9?3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan. International journal of hypertension 2022 3 2022 7677252. Liu Yi, Kong Xiaomu, Jiang Yongwei, Zhao Meimei, Gao Peng, Cong Xiao, Cao Yongtong, Ma Lia |
Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study. Kidney360 2022 3 3 (2): 307-316. Eadon Michael T, Maddatu Judith, Moe Sharon M, Sinha Arjun D, Ferreira Ricardo Melo, Miller Brent W, Sher S Jawad, Su Jing, Pratt Victoria M, Chapman Arlene B, Skaar Todd C, Moorthi Ranjani |
CYP2C9 gene polymorphisms influence on antihypertensive effectiveness and hypouricemic effect of losartan among patients with arterial hypertension: an observational study. Drug metabolism and personalized therapy 2022 12 . Sinitsina Irina I, Boyarko Alexey V, Temirbulatov Ilyas I, Sychev Dmitry A, Akmalova Kristina A, Sozaeva Zhannet A, Grishina Elena A, Mirzaev Karin B, Asoskova Anastasiia V, Fisenko Vladimir |
Pharmacological counseling in hepatotoxicity induced by macitentan and selexipag: a case report. Journal of medical case reports 2022 10 16 (1): 385. Lattanzio Mariangela, Ferrari Marco, Martini Stefano, Ceriani Francesca, Imporzani Andrea, Marino Franca, De Ponti Roberto, Cosentino Mar |
null. Drug metabolism and disposition: the biological fate of chemicals 2023 9 . Youhao Chen, Yaobin Lin, Shaoxing Guan, Zerui Zhao, Daren Lin, Jin Guan, Chengzhi Zhou, Junling Liu, Xiaolong Cao, Zhichao Lin, Diyao Chen, Jianbiao Shang, Weijian Zhang, Huohui Chen, Likun Chen, Shudong Ma, Lijia Gu, Jian Zhao, Min Huang, Xueding Wang, Hao Lo |
Effects of genetic polymorphisms of CYP2J2, CYP2C9, CYP2C19, CYP4F2, CYP4F3 and CYP4A11 enzymes in preeclampsia and gestational hypertension. Placenta 2023 5 137 88-95. Mert C Ongun, Nazan Vanli Tonyali, Ozan Kaplan, Ilter Deger, Mustafa Celebier, Nursabah E Basci Akduman, Dilek Sahin, Aykan Yucel, Melih O Babaog |
Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study. Pharmaceuticals (Basel, Switzerland) 2023 5 16 (5): . Ana Batinic, Davorka Sutlovi?, Sendi Kuret, Antonela Matana, Marko Kumric, Josko Bozic, Zeljko Duj |
Genetic and phenotypic frequency distribution of ACE, ADRB1, AGTR1, CYP2C9*3, CYP2D6*10, CYP3A5*3, NPPA and factors associated with hypertension in Chinese Han hypertensive patients. Medicine 2023 3 102 (10): e33206. Wang Zhenyun, Hou Juanjuan, Zheng Hongjun, Wang Dan, Tian Weihua, Zhang Dan, Yan Jiam |
Fibrinogen-A? THR312ALA Polymorphism is Associated to Chronic Thromboembolic Pulmonary Hypertension in Turkey. Anatolian journal of cardiology 2023 3 27 (3): 153-159. Çörtük Mustafa, Y?ld?zeli Bedrettin, Kurar Ercan, Kay?? Seyit Ali, Tanr?verdi Elif, Çetinkaya Erdo? |
Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes. Archives of pharmacal research 2023 12 . Chang-Keun Cho, Pureum Kang, Choon-Gon Jang, Seok-Yong Lee, Yun Jeong Lee, Chang-Ik Ch |
Acute kidney injury interacts with VKORC1 genotype on initiative warfarin dose among heart surgery recipients: a real-world research. Scientific reports 2023 12 13 (1): 21750. Liang Xiong, Feng Yu, Weihong Ge, Hang |
Genetic variation of CYP2C9 gene and its correlation with cardiovascular disease risk factors. Molecular biology reports 2024 1 51 (1): 105. Ghada S Rasool, Salwa J Al-Awadi, Asmaa A Hussien, Marwa M Al-Att |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: